These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6374194)

  • 1. [Pharmacokinetic studies on ceftazidime in the obstetrical and gynecological field].
    Ito K; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1984 Jan; 37(1):18-22. PubMed ID: 6374194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fundamental study of ceftriaxone in the field of obstetrics and gynecology].
    Itoh K; Kondoh H; Hayasaki M; Noda K
    Jpn J Antibiot; 1984 Dec; 37(12):2343-8. PubMed ID: 6098727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental and clinical studies on aztreonam in the field of obstetrics and gynecology].
    Ito K; Matsunami K; Hayasaki M; Noda K
    Jpn J Antibiot; 1985 Dec; 38(12):3619-28. PubMed ID: 3834147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic and clinical studies on ceftazidime in the field of obstetrics and gynecology].
    Doko F
    Jpn J Antibiot; 1984 Jan; 37(1):57-62. PubMed ID: 6374200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Ito K; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1984 Nov; 37(11):2193-202. PubMed ID: 6098712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on antimicrobial concentrations of flomoxef in serum, pelvic dead space exudate, and pelvic organs/tissues].
    Obata T; Koishi K; Sasaki J; Eguchi M; Yamamoto Y
    Jpn J Antibiot; 1987 Oct; 40(10):1820-9. PubMed ID: 3444023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A fundamental study on T-1982 (cefbuperazone) in the field of obstetrics a gynecology].
    Itoh K; Iwasa S; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1983 May; 36(5):982-5. PubMed ID: 6620566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundamental and clinical studies of ceftazidime in the field of obstetrics and gynecology].
    Shintani M; Takashima K; Kosakai H; Takayama T; Nakanishi A; Shimamoto I; Ichijo M
    Jpn J Antibiot; 1984 Jan; 37(1):28-32. PubMed ID: 6374196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental and clinical studies of cefpimizole in obstetrics and gynecology].
    Ito K; Matsunami K; Hayasaki M; Noda K; Baba Y; Kondo H
    Jpn J Antibiot; 1985 Apr; 38(4):972-81. PubMed ID: 4032734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental and clinical studies on ceftazidime].
    Seiga K; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1984 Jan; 37(1):38-48. PubMed ID: 6374198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on antimicrobial concentration of clindamycin phosphate in serum, pelvic dead space exudate, and pelvic organs/tissues].
    Obata T; Sasaki J; Takahashi K; Eguchi M; Yamamoto Y; Deguchi K; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1986 Feb; 39(2):317-25. PubMed ID: 3712747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic and clinical studies on ceftazidime in the field of obstetrics and gynecology].
    Cho N; Hara Y; Noguchi Y; Kondo H; Murakami M; Seki M; Maruyama M; Aoki K; Fukunaga K; Kunii K
    Jpn J Antibiot; 1983 Dec; 36(12):3463-75. PubMed ID: 6371294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental and clinical studies on aztreonam].
    Hirabayashi K; Okada E
    Jpn J Antibiot; 1985 Dec; 38(12):3674-82. PubMed ID: 3834154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental and clinical studies on cefpimizole in the field of obstetrics and gynecology].
    Horii T; Kitamura K; Ikeda M; Shiota M; Teshima K; Noda K
    Jpn J Antibiot; 1985 Apr; 38(4):995-1000. PubMed ID: 4032736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
    Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
    Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic and clinical studies on cefminox in the field of obstetrics and gynecology].
    Itoh K; Kondo H; Hayasaki M; Noda K
    Jpn J Antibiot; 1985 May; 38(5):1244-53. PubMed ID: 3930793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic, bacteriological and clinical studies of cefuzonam in the field of obstetrics and gynecology].
    Ito K; Iida K; Kondo H; Noda K; Hayasaki M; Sumi H; Kadomoto N
    Jpn J Antibiot; 1987 May; 40(5):1066-73. PubMed ID: 3669285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cephem antibiotics in exudate of pelvic retroperitoneal space after radical hysterectomy and pelvic lymphadenectomy.
    Ito K; Hayasaki M; Tamaya T
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1160-4. PubMed ID: 2393276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Piperacillin concentration in the pelvic dead space exudate following surgery of cervical cancer].
    Koike K; Ohshima T
    Jpn J Antibiot; 1983 Oct; 36(10):2820-4. PubMed ID: 6674517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical studies on ceftazidime in the field of obstetrics and gynecology].
    Horii T; Suzuki H; Takashima Y; Noda K
    Jpn J Antibiot; 1984 Jan; 37(1):33-7. PubMed ID: 6374197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.